Drug · DIN 02539454
PLERIXAFOR INJECTION
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 5, 2024; first marketed January 5, 2024.
- Drug Identification Number (DIN)
- 02539454
- Company (DIN owner)
- Eugia Pharma Inc.Woodbridge, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Plerixafor L03AX16
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PLERIXAFOR | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 11, 2023: NOC 31176Abbreviated New Drug Submission (ANDS)
Other DINs named PLERIXAFOR INJECTION
- DIN 02529815 · Marketed
- DIN 02490846 · Approved